250 related articles for article (PubMed ID: 26135741)
1. Chronic Dietary Administration of the Glycolytic Inhibitor 2-Deoxy-D-Glucose (2-DG) Inhibits the Growth of Implanted Ehrlich's Ascites Tumor in Mice.
Singh S; Pandey S; Bhatt AN; Chaudhary R; Bhuria V; Kalra N; Soni R; Roy BG; Saluja D; Dwarakanath BS
PLoS One; 2015; 10(7):e0132089. PubMed ID: 26135741
[TBL] [Abstract][Full Text] [Related]
2. 2-Deoxyglucose as an energy restriction mimetic agent: effects on mammary carcinogenesis and on mammary tumor cell growth in vitro.
Zhu Z; Jiang W; McGinley JN; Thompson HJ
Cancer Res; 2005 Aug; 65(15):7023-30. PubMed ID: 16061689
[TBL] [Abstract][Full Text] [Related]
3. Enhanced antitumor immunity contributes to the radio-sensitization of ehrlich ascites tumor by the glycolytic inhibitor 2-deoxy-D-glucose in mice.
Farooque A; Singh N; Adhikari JS; Afrin F; Dwarakanath BS
PLoS One; 2014; 9(9):e108131. PubMed ID: 25248151
[TBL] [Abstract][Full Text] [Related]
4. Radiosensitization of murine Ehrlich ascites tumor by a combination of 2-deoxy-D-glucose and 6-aminonicotinamide.
Varshney R; Gupta S; Dwarakanath BS
Technol Cancer Res Treat; 2004 Dec; 3(6):659-63. PubMed ID: 15560724
[TBL] [Abstract][Full Text] [Related]
5. The glycolytic inhibitor 2-deoxy-D-glucose enhances the efficacy of etoposide in ehrlich ascites tumor-bearing mice.
Gupta S; Mathur R; Dwarakanath BS
Cancer Biol Ther; 2005 Jan; 4(1):87-94. PubMed ID: 15711125
[TBL] [Abstract][Full Text] [Related]
6. Dietary 2-deoxy-D-glucose impairs tumour growth and metastasis by inhibiting angiogenesis.
Singh S; Pandey S; Chawla AS; Bhatt AN; Roy BG; Saluja D; Dwarakanath BS
Eur J Cancer; 2019 Dec; 123():11-24. PubMed ID: 31670076
[TBL] [Abstract][Full Text] [Related]
7. Enhancing targeted radiotherapy by copper(II)diacetyl- bis(N4-methylthiosemicarbazone) using 2-deoxy-D-glucose.
Aft RL; Lewis JS; Zhang F; Kim J; Welch MJ
Cancer Res; 2003 Sep; 63(17):5496-504. PubMed ID: 14500386
[TBL] [Abstract][Full Text] [Related]
8. Polarization of macrophages towards M1 phenotype by a combination of 2-deoxy-d-glucose and radiation: Implications for tumor therapy.
Farooque A; Afrin F; Adhikari JS; Dwarakanath BS
Immunobiology; 2016 Feb; 221(2):269-81. PubMed ID: 26597503
[TBL] [Abstract][Full Text] [Related]
9. Targeting the ROS/PI3K/AKT/HIF-1α/HK2 axis of breast cancer cells: Combined administration of Polydatin and 2-Deoxy-d-glucose.
Zhang T; Zhu X; Wu H; Jiang K; Zhao G; Shaukat A; Deng G; Qiu C
J Cell Mol Med; 2019 May; 23(5):3711-3723. PubMed ID: 30920152
[TBL] [Abstract][Full Text] [Related]
10. Hematoporphyrin derivatives potentiate the radiosensitizing effects of 2-deoxy-D-glucose in cancer cells.
Dwarakanath BS; Adhikari JS; Jain V
Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):1125-33. PubMed ID: 10192364
[TBL] [Abstract][Full Text] [Related]
11. Comparative investigation of the effect of ukrain on growth of ascites and solid forms of Ehrlich's carcinoma.
Susak YM; Skivka LM; Rudik MP; Pozur VV; Liubunya AV
Exp Oncol; 2010 Jul; 32(2):107-10. PubMed ID: 20693973
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic and antitumor effects of brucine on Ehrlich ascites tumor and human cancer cell line.
Agrawal SS; Saraswati S; Mathur R; Pandey M
Life Sci; 2011 Aug; 89(5-6):147-58. PubMed ID: 21684292
[TBL] [Abstract][Full Text] [Related]
13. Optimization of tumor radiotherapy. Part VI: Modification of tumor glucose metabolism for increasing the bioavailability of 2-deoxy-D-glucose (2-DG) in a murine tumor model.
Sharma RK; Singh S; Degaonkar M; Raghunathan P; Maitra A; Jain V
Strahlenther Onkol; 2000 Mar; 176(3):135-43. PubMed ID: 10742835
[TBL] [Abstract][Full Text] [Related]
14. Glycolytic Inhibitor 2-Deoxy-D-Glucose at Chronic Low Dose Mimics Calorie Restriction in Rats Through Mitohormetic Induction of Reactive Oxygen Species.
Saraswat K; Kumar R; Rizvi SI
Rejuvenation Res; 2019 Oct; 22(5):377-384. PubMed ID: 30451072
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of established rat fibrosarcoma growth by the glucose antagonist 2-deoxy-D-glucose.
Kern KA; Norton JA
Surgery; 1987 Aug; 102(2):380-5. PubMed ID: 3039679
[TBL] [Abstract][Full Text] [Related]
16. Targeting hypoxia, a novel treatment for advanced retinoblastoma.
Boutrid H; Jockovich ME; Murray TG; Piña Y; Feuer WJ; Lampidis TJ; Cebulla CM
Invest Ophthalmol Vis Sci; 2008 Jul; 49(7):2799-805. PubMed ID: 18326690
[TBL] [Abstract][Full Text] [Related]
17. Separate and concurrent use of 2-deoxy-D-glucose and 3-bromopyruvate in pancreatic cancer cells.
Xiao H; Li S; Zhang D; Liu T; Yu M; Wang F
Oncol Rep; 2013 Jan; 29(1):329-34. PubMed ID: 23076497
[TBL] [Abstract][Full Text] [Related]
18. Drug/diet synergy for managing malignant astrocytoma in mice: 2-deoxy-D-glucose and the restricted ketogenic diet.
Marsh J; Mukherjee P; Seyfried TN
Nutr Metab (Lond); 2008 Nov; 5():33. PubMed ID: 19032781
[TBL] [Abstract][Full Text] [Related]
19. Preventive effect of ethanol extract of Alpinia calcarata Rosc on Ehrlich's ascitic carcinoma cell induced malignant ascites in mice.
Perveen R; Islam F; Khanum J; Yeasmin T
Asian Pac J Trop Med; 2012 Feb; 5(2):121-5. PubMed ID: 22221755
[TBL] [Abstract][Full Text] [Related]
20. Caloric Restriction Mimetic 2-Deoxyglucose Alleviated Inflammatory Lung Injury
Hu K; Yang Y; Lin L; Ai Q; Dai J; Fan K; Ge P; Jiang R; Wan J; Zhang L
Front Immunol; 2018; 9():426. PubMed ID: 29552018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
